Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Hankerchiefon Nov 29, 2018 9:20am

43 Views

Post# 29038580

RE:RE:Where are the data

We assume that patient 6 has had the 270 day follow up but maybe that has not happened yet. Folks travel or have schedule issues that may have changed that. I agree that no matter the result it would be good to know. Plus they could always re treat the patient if need be. Since investors are expecting the results it would be nice to have the company put out some info even if it is that the patient hasn't had the follow up yet. I emailed the company about this and have not heard anything back yet.

Bullboard Posts

Golden Minerals closes Yoquivo gold-silver project sale